MedTrace Logo

Comparison of Extra-Virgin and Refined Olive Oil on Some Cardiovascular Risk Factors

NCT03796780 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-12-10

No results posted yet for this study

Summary

Consumption of extra-virgin olive oil has beneficial effects on cardiovascular risk factors. The purpose of this study is to compare the effects of extra-virgin olive oil and refined olive oil, in adjunct to conventional medical treatment, in improving liver enzymes, plasma lipid profile and inflammatory markers in patients with cardiovascular risk factors.

Conditions

  • Cardiovascular Risk Factor

Interventions

DIETARY_SUPPLEMENT

Extra-Virgin Olive Oil

Daily consumption of 25 mL Extra-Virgin Olive Oil in adjunct to medical treatment for 6 weeks

DIETARY_SUPPLEMENT

Refined Olive Oil

Daily consumption of 25 mL Refined Olive Oil in adjunct to medical treatment for 6 weeks

Sponsors & Collaborators

  • Shahid Beheshti University of Medical Sciences

    collaborator OTHER

  • Javad Nasrollahzadeh

    lead OTHER

Principal Investigators

  • Javad Nasrollahzadeh, Ph.D · Shahid Beheshti University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2019-09-01
Completion
2019-10-01

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03796780 on ClinicalTrials.gov